Figure 5.

Effects of cycloastragenol against memory dysfunction in Aβ-injected mice. (a) Graph showing the latency to reach the platform during the training days. (b) Latency on day 6 after the completion of training. (c) Probe test, number of crossings of the platform. (d) Time spent in the target quadrant. The p-value < 0.05 was considered a significant difference. * showing a significant difference from the control group; # significantly different from the Aβ-injected group. Significance = * p < 0.05; # p < 0.05. CAG 20: Cycloastragenol 20 mg/kg, Aβ: Amyloid beta, CAG: cycloastragenol, ns: non-significant difference.